Locations across Queensland within Queensland Cardiovascular Group

Phone (07) 3016 1111

our doctors

Dr Roland Hilling-Smith

MBChB | FRACP

Education and
Training

Fellowship in Advanced Coronary and Structural Intervention
Royal Sussex County Hospital | Sussex, England

Fellowship in Interventional Cardiology
Princess Alexandra Hospital | Brisbane, Australia

Fellow of the Royal Australasian College of Physicians (FRACP)
Royal Australasian College of Physicians | Australia

Bachelor of Medicine, Bachelor of Surgery (MBChB)
Edinburgh University | Edinburgh, Scotland

Procedures and Conditions related to Atrial Fibrillation

left atrial appendage closure
Left Atrial Appendage Closures

Dr Roland Hilling-Smith is a Specialist Interventional Cardiologist, performing a wide variety of cardiac procedures.

In particular for Atrial Fibrillation patients, Dr Hilling-Smith performs the Left Atrial Appendage Closure Procedure (specific devices may be known as Watchman, Amplatzer, Amulet and others).

About Dr Roland Hilling-Smith

Dr Roland Hilling-Smith, a Director of Queensland Cardiovascular Group, is a clinical cardiologist with sub-specialty expertise in interventional cardiology

His main focus is on coronary and structural intervention. Unusually for an interventional cardiologist, Dr Hilling-Smith is also trained, accredited and performs cardiac CT, providing a unique perspective in the investigation, diagnosis and management of cardiovascular diseases.

Dr Hilling-Smith performs a wide range of percutaneous interventional procedures including coronary stents, rotablation and chronic total occlusion revascularisation.

He performs the full range of structural interventions including TAVI, PFO / ASD closure, percutaneous treatments of aortic and mitral valves, left atrial appendage occlusion and renal denervation amongst others.

Dr Hilling-Smith is a TAVI proctor, providing on-site training, evaluation and observation of other cardiologists and healthcare professionals on the safe and correct use of transcatheter aortic valve replacement.

He ensures appropriate selection of patient, device and system, implant technique, and recognises and addresses special clinical conditions, such as potential complications. 

He studied medicine at Edinburgh University, Scotland. He trained in general medicine at Fremantle Hospital and cardiology at the prestigious MonashHeart in Melbourne. He has undertaken two interventional fellowships, firstly locally at Princess Alexandra Hospital in Brisbane. He was then awarded the Chamberlain Scholarship in Advanced Coronary and Structural Intervention at the world renowned Royal Sussex County Hospital, England. During his time there, Dr Hilling-Smith was involved in many international trials and several first-in-man developments.

Dr Hilling-Smith is now a proctor (teaches other consultants) in structural techniques including TAVI procedure. He has published several research manuscripts, written a book chapter and spoken at international conferences. He is involved in several ongoing collaborative research projects, primarily in the field of improving patient outcomes following percutaneous structural intervention.

Dr Hilling-Smith is a VMO at St Andrew’s War Memorial Hospital in Spring Hill, Mater Hospital (both public and private), Greenslopes Hospital and St Andrew’s Hospital in Ipswich.

He is also a proud member of the Heart of Australia project providing cardiovascular care to regional and remote Queensland.

Professional Memberships
and Awards

Heart of Australia
Cardiologist

Royal Australasian College of Physicians (FRACP)
Fellow

surgery

Research and Publications​

  1. Augmentation index assessed by applanation tonometry is elevated in Marfan Syndrome. Journal of Cardiothoracic Surgery 2:43, 2007
  1. Myocardial Density Analysis Utilizing Automated Myocardial Defect Analysis Software on Resting 320 Detector MDCT Int J Cardiovasc Imaging. 2013 Jun; 29(5):1121-7
  2. Mitral paravalvular leak closure by antegrade percutaneous approach using amplatzer PFO closure device.Catheter Cardiovasc Interv. 2016 Apr 16.
  3. Rapid pacing using the 0.035-in. Retrograde left ventricular support wire in 208 cases of transcatheter aortic valve implantation and balloon aortic valvuloplasty. Catheter Cardiovasc Interv. 2017 Mar 1; 89(4):783-786
  4. Transradial and transfemoral percutaneous closure of iatrogenic perimembranous Ventricular Septal Defects using the Amplatzer AVP IV device. Int J Cardiol. 2016 Dec 1; 224:65-68
  5. Use of the Lotus Transcatheter Valve to Treat Severe Native Aortic Regurgitation. Ann Thorac Surg. 2017 Apr; 103(4):e305-e307
  6. Conduction Abnormalities and Permanent Pacemaker Implantation After Transcatheter Aortic Valve Replacement Using the Repositionable LOTUS Device: The United Kingdom Experience. JACC Cardiovasc Interv. 2017 Jun 26; 10(12):1247-1253
  7. Occlutech percutaneous patent foramen ovale closure: Safety and efficacy registry (OPPOSE). Int J Cardiol. 2017 Oct 15; 245:99-10